Powered by
-
MRK Stock Chart
Historical MRK Prices
Merck & Co Stock Analysis
Rating: Sell
Total Grade: D
Analysis Breakdown
| MRK Stock Grade: | D |
| Fundamental Grade: | C |
| Quantitative Grade: | D |
| MRK Earnings | |
| Earnings Growth: | C |
| Earnings Momentum: | C |
| Earnings Surprises: | C |
| Analyst Earnings Revisions: | C |
| MRK Financial Information | |
| Sales Growth: | D |
| Operating Margin Growth: | C |
| Cash Flow: | F |
| Return on Equity: | C |
Merck & Co Stock: Weekly View
| This Week: | D |
|---|---|
| Last Week: | D |
| Two Weeks Ago: | F |
MRK Stock predictions, Articles, and Merck & Co News
- From InvestorPlace
- From the Web
-
10 Retirement Stocks That You Should Already Own - April 17, 2018
If you're looking for a safe and stable mix of growth and income while you're still working, these names are your best long-term bets. Continue…
-
Stocks Push Forward As Fears of War Diminish - April 17, 2018
Stocks climbed again on Monday, shrugging off the U.S.-led airstrike on Syria over the weekend. Now the market will get an update on U.S. industrial production as well as a batch of Federal Reserve policymaker speeches. Continue…
-
7 Monster Market Trends and 7 Ways to Invest - April 16, 2018
These seven monster market trends are just where investors need to focus over the coming year to thwart the current volatility, no matter how it resolves. Continue…
-
3 Reasons to Be Bullish on Merck & Co., Inc. Stock - April 10, 2018
Merck has had a tough year. But this does look like an opportunity for investors. MRK has a robust pipeline and Keytruda should continue to propel growth. Continue…
-
Expect Stocks to Rise on Continued Bullishness - April 10, 2018
The bulls blasted stocks higher out of the gate yesterday, and you can expect that to continue today after trade war concerns were dampened by Chinese President Xi Jinping's latest announcement. Continue…
-
10 Safe Dividend Stocks for the Second Quarter - April 6, 2018
These 10 dividend stocks have been paying their shareholders for a long time and have a history of increases. Continue…
-
Incyte Corporation Stock Plunges on Melanoma Drug Trial Failure - April 6, 2018
Incyte (INCY) was falling hard on Friday following news of a failed Phase 3 drug trial for its melanoma drug epacadostat. Continue…
-
4 Dow Titans That Could Slap the Mat - April 3, 2018
There are too many headwinds -- from the threat of regulation to systemic worries about Federal Reserve tightening -- mixed with the fact investors were too aggressively positioned in key Big Tech stocks. These four Dow stocks could be in for a breakdown. Continue…
-
3 Bear Trades on the Verge of Big-League Breakdowns - March 26, 2018
With bears roaming and support levels disintegrating, it's time to consider stocks for shortselling. Here are three bear trades on the cusp of major breakdowns. Continue…
-
10 Risky (But Rewarding) Small-Cap Stocks to Buy Now - February 28, 2018
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward. Continue…
